BioSpace News Archive

Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced that its Board of Directors has unanimously appointed Pam Prior, CPA, to the Board.

Yisheng Biopharma Co., Ltd. and Tavotek Biotherapeutics announced that the companies have entered into a strategic research alliance and collaborate in the development involving their lead assets in oncology.

Catapult Health, the leading national provider of onsite preventive health checkups, welcomes Art Dickerson as Chief Revenue Officer

Pomerantz LLP is investigating claims on behalf of investors of Allakos Inc. Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

Perrigo Company plc (NYSE; TASE: PRGO) announced today that its Ranir subsidiary has acquired the assets of Steripod®, a leading toothbrush accessory brand and innovator in the toothbrush protector market, from Bonfit America Inc.

Neuronasal’s potentially ground-breaking, proprietary treatment includes the intranasal delivery of low doses of N-acetylcysteine to patients with acute mTBI.

Biotech Showcase™ 2020, to be held January 13–15, 2020, during the most important week in healthcare at the Hilton San Francisco Union Square.

Veteran leasing, development, and legal professionals recognized for significant contributions

Revive aims to build a portfolio of cannabinoid-based drugs for the treatment of rare inflammatory diseases with its initial focus on Autoimmune liver diseases

BioSpace, the leader in life sciences news and careers, today announced their NextGen Bio “Class of 2020,” a list of 21 up-and-coming life sciences companies in the United States.